Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit
Authors
Keywords
-
Journal
PROSTATE
Volume 73, Issue 4, Pages 428-441
Publisher
Wiley
Online
2012-09-19
DOI
10.1002/pros.22584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
- (2012) Mauro Gacci et al. EUROPEAN UROLOGY
- Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells
- (2012) Linda Vignozzi et al. JOURNAL OF ENDOCRINOLOGY
- Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome
- (2012) Annamaria Morelli et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Reduced Vascular Nitric Oxide–cGMP Signaling Contributes to Adipose Tissue Inflammation During High-Fat Feeding
- (2011) Priya Handa et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Correlation Between Metabolic Syndrome and Prostatic Diseases
- (2011) Cosimo De Nunzio et al. EUROPEAN UROLOGY
- Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit
- (2011) Linda Vignozzi et al. JOURNAL OF ENDOCRINOLOGY
- Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats
- (2011) Annamaria Morelli et al. Journal of Sexual Medicine
- Spermatogenic and sperm quality differences in an experimental model of metabolic syndrome and hypogonadal hypogonadism
- (2011) Con Mallidis et al. REPRODUCTION
- Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism?
- (2011) Andrea Armani et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Differentiation of Effector CD4 T Cell Populations
- (2010) Jinfang Zhu et al. Annual Review of Immunology
- Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes
- (2010) Annamaria Morelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia
- (2010) Chen Zhao et al. BJU INTERNATIONAL
- Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms
- (2010) JK Parsons CURRENT OPINION IN UROLOGY
- Attenuated Proliferation andTrans-Differentiation of Prostatic Stromal Cells Indicate Suitability of Phosphodiesterase Type 5 Inhibitors for Prevention and Treatment of Benign Prostatic Hyperplasia
- (2010) Christoph Zenzmaier et al. ENDOCRINOLOGY
- Vardenafil Decreases Bladder Afferent Nerve Activity in Unanesthetized, Decerebrate, Spinal Cord–Injured Rats
- (2010) Delphine Behr-Roussel et al. EUROPEAN UROLOGY
- Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes
- (2010) Linda Vignozzi et al. Journal of Sexual Medicine
- Testosterone and Metabolic Syndrome: A Meta‐Analysis Study
- (2010) Giovanni Corona et al. Journal of Sexual Medicine
- The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment
- (2010) Daniella Bianchi-Frias et al. PLoS One
- Lower urinary tract symptoms, obesity and the metabolic syndrome
- (2009) Samdeep Moul et al. CURRENT OPINION IN UROLOGY
- Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha
- (2009) Thierry Roumeguère et al. EUROPEAN UROLOGY
- Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases
- (2009) G. Corona et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Chronic inflammation in the pathogenesis of benign prostatic hyperplasia
- (2009) B. Fibbi et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation
- (2009) G. Penna et al. JOURNAL OF IMMUNOLOGY
- Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome
- (2009) Sandra Filippi et al. Journal of Sexual Medicine
- Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats
- (2009) Annamaria Morelli et al. Journal of Sexual Medicine
- Acute Vardenafil Administration Improves Bladder Oxygenation in Spontaneously Hypertensive Rats
- (2009) Annamaria Morelli et al. Journal of Sexual Medicine
- Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract
- (2009) Benedetta Fibbi et al. Journal of Sexual Medicine
- Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity
- (2009) Anne K. Mongiu et al. Current Urology Reports
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started